Friday, November 20, 2026

TherapeuticsMD Stock Went Up By Over 27% In The Last 21 Sessions

Automated market report from our archive (2020-2024), published before source-traceability. How we work

TherapeuticsMD Stock Went Up By Over 27% In The Last 21 Sessions

(VIANEWS) - Shares of TherapeuticsMD (NASDAQ: TXMD) jumped by a staggering 27.25% in 21 sessions from $3.67 at 2023-04-17, to $4.67 at 11:55 EST on Tuesday, following the last session's downward trend. NASDAQ is rising 0.17% to $12,386.53, following the last session's upward trend.

TherapeuticsMD's last close was $4.39, 62.45% below its 52-week high of $11.69.

About TherapeuticsMD

TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Earnings Per Share

As for profitability, TherapeuticsMD has a trailing twelve months EPS of $0.11.

PE Ratio

TherapeuticsMD has a trailing twelve months price to earnings ratio of 42.45. Meaning, the purchaser of the share is investing $42.45 for every dollar of annual earnings.

Volatility

TherapeuticsMD's last week, last month's, and last quarter's current intraday variation average was 4.63%, 1.06%, and 3.04%.

TherapeuticsMD's highest amplitude of average volatility was 4.63% (last week), 3.11% (last month), and 3.04% (last quarter).

Sales Growth

TherapeuticsMD's sales growth is negative 91.2% for the present quarter and negative 93.7% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TherapeuticsMD's stock is considered to be oversold (<=20).

Volume

Today's last reported volume for TherapeuticsMD is 13091 which is 68.6% below its average volume of 40045.

More news about TherapeuticsMD (TXMD).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 16 May 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.